Opportunity
SAM #OII-2027-133938
FDA Biomanufacturing Training Curriculum Development and Delivery
Buyer
FDA Office of the Associate General Counsel for Administrative Law
Posted
November 17, 2026
Respond By
December 01, 2027
Identifier
OII-2027-133938
NAICS
611430
The FDA is seeking market-research responses for a multi-year biomanufacturing training program for its investigators. - Government buyer: U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Office of Inspections and Investigations (OII), Office of Training, Education, and Development (OTED). - Requested services: One contractor to develop, maintain, and deliver a four-course curriculum: - Upstream Bioprocessing - Downstream Bioprocessing - QC/Analytical Testing - Aseptic Processing - Course format and capacity: Each course is five weeks, supports up to 25 students, and provides 32 contact hours: 8 online and 24 onsite, including three days of classroom and hands-on facility training. Delivery includes web-based learning through BTEC Shorts, webinars, and onsite instruction. - Additional work: Program and project management; courseware development, testing, and maintenance; instructor and participant guides; assessments and remediation; evaluation; and a train-the-trainer package. - Notable requirements: Content must be accessible under Section 508, SCORM-conformant, and compatible with FDA networks. The contractor must review and update content annually. The first course is expected to be ready for enrollment within six months of award, all curriculum must be available by the end of the base year, and six cohorts are to complete the series by the end of option year four. - OEMs and vendors: No OEMs or contractor vendors are identified. BTEC Shorts is named as a delivery platform. - Notice context: This is market research, not a formal solicitation or commitment to award. The FDA anticipates a potential stand-alone contract and requests a vendor feedback form, a capability statement, and optional comments on the draft Statement of Work.
Description
FOOD AND DRUG ADMINISTRATION (FDA)
OFFICE OF INSPECTIONS AND INVESTIGATIONS (OII)
BIOMANUFACTURING PRINCIPLES AND PROCESSES TRAINING SERIES
SOURCES SOUGHT NOTICE (SSN)
Description
The U.S. Food and Drug Administration's (FDA), Office of Acquisitions and Grants Services (OAGS), is conducting market research for obtaining Biomanufacturing Principles and Processes Training services.
THIS IS A SOURCES SOUGHT NOTICE (SSN) ONLY. This SSN is being issued in accordance with Federal Acquisition Regulation (FAR) Part 10, Market Research. It is for information, planning and market research purposes only and is not to be construed as a commitment by the Government to issue a solicitation or ultimately award a contract. This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. The Government reserves the right to contact any of the respondents after the submission deadline if additional information is required.
The purpose of this SSN is to identify and gain knowledge of potential business sources and small business sources that are capable of providing the full range of services described in this SSN and the attached Draft Statement of Work (SOW). Responses to this SSN will be utilized for a potential solicitation for an anticipated stand-alone contract for the Biomanufacturing Principles and Processes Training Program. The anticipated period of performance for this contract is March 2027 through March 2032 (base year, plus four (4) option years), with a potential 6-month extension of services pursuant to FAR 52.217-8, for a total potential period of performance through September 2032.
Requested Information
Interested parties are highly encouraged to respond to this SSN by providing the following information in their response:
Completed Vendor Feedback Form – See attached Vendor Feedback Form If applicable, tracked changes/comments on draft SOW in MS Word format – See attached Draft SOW Capability Statement
Responses shall be submitted via email with the subject line "Sources Sought Notice - FDA SSN: OII-2027-133938” to the Contracting Officer, Nicholas Bisher (Nicholas.Bisher@fda.hhs.gov), no later than 12:00pm (Eastern) on December 1, 2026.
Attachments
Vendor Feedback Form Draft Statement of Work